<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One third of <z:hpo ids='HP_0000001'>all</z:hpo> extranodal sites of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are localized to the digestive tract </plain></SENT>
<SENT sid="1" pm="."><plain>Forty-six cases with digestive tract localization were studied, of which 15 were localized forms </plain></SENT>
<SENT sid="2" pm="."><plain>Histologically, 70 p. cent were diffuse <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with poor prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>The present survival rate for localized forms following chemotherapy is 77 p. cent, which plateaux at two years, as compared to 34 p. cent for disseminated forms </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment of digestive tract localizations should be similar to that of nodal forms with the same histology </plain></SENT>
<SENT sid="5" pm="."><plain>With the development of intensive chemotherapeutic regimens over the last few years, the cure rate is hoped to attain 65 p. cent in disseminated forms, and 87 p. cent in localized forms </plain></SENT>
</text></document>